CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential

Author:

Deaglio Silvia12,Vaisitti Tiziana12,Aydin Semra12,Bergui Luciana3,D'Arena Giovanni4,Bonello Lisa2,Omedé Paola3,Scatolini Maria5,Jaksic Ozren6,Chiorino Giovanna5,Efremov Dimitar7,Malavasi Fabio12

Affiliation:

1. Department of Genetics, Biology and Biochemistry, University of Torino Medical School, Turin, Italy;

2. Research Center for Experimental Medicine (CeRMS), University of Torino Medical School, Turin, Italy;

3. Department of Medicine and Experimental Oncology, University of Torino Medical School, Turin, Italy;

4. Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Naples, Italy;

5. Fondo Edo Tempia, Biella, Italy;

6. Department of Hematology, Merkur University Hospital, Zagreb, Croatia; and

7. International Centre for Genetic Engineering and Biotechnology (ICGEB) Outstation—Monterotondo, Consiglio Nazionale delle Ricerche (CNR) Campus Adriano Buzzati-Traverso, Rome, Italy

Abstract

Abstract Our interest in chronic lymphocytic leukemia (CLL) derives primarily from the exploitation of human diseases as strategic models for defining the in vivo biological roles of CD38. Using this model, we showed that CD38 triggers robust proliferation/survival signals modulated through the interactions with the CD31 ligand expressed by nurselike cells and by the stromal/endothelial components. By analyzing a cohort of 56 patients with clinically and molecularly characterized CLL, we show that (1) patients with CD38+/ZAP-70+ are characterized by enhanced migration toward Stromal derived factor-1α (SDF-1α)/CXCL12; (2) CD38 ligation leads to tyrosine phosphorylation of ZAP-70, showing that these markers are functionally linked; (3) ZAP-70 represents a limiting factor for the CD38 pathway in the CLL context, as shown by studying CD38-mediated signal transduction in 26 molecularly characterized patients; and (4) the CLL subgroup of patients defined on the basis of migratory potential is marked by a specific genetic signature, with a significant number of differentially expressed genes being involved in cell-cell interactions and movement. Altogether, the results of this work provide biological evidence for why the combined analysis of CD38 and ZAP-70 expression as determined in several clinical trials results in more dependable identification of patients with CLL who have aggressive disease.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference53 articles.

1. The CD38/CD157 mammalian gene family: an evolutionary paradigm for other leukocyte surface enzymes.;Deaglio;Purinergic Signal,2006

2. CD38: an ecto-enzyme at the crossroads of innate and adaptive immune responses.;Partida-Sanchez;Adv Exp Med Biol,2007

3. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member.;Deaglio;J Immunol,1998

4. CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes.;Deaglio;Chem Immunol,2000

5. CD38 as a prognostic marker in CLL.;Matrai;Hematology,2005

Cited by 137 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3